July 9 (UPI) — The Food and Drug Administration on Thursday recalled more than 2.5 million bottles of eye drops because they may contain a “foreign substance.”
The nationwide recall was initiated by Lupin Pharmaceuticals on June 4 because of some type of foreign substance, though the company and the FDA have not identified it or how it got into the eye drops, MassLive and NJ.com reported.
The class II recall of the prednisolone acetate eye drops — used to reduce inflammation after eye surgery or for allergic and other conditions — is the second-highest risk recall for the agency because it may cause adverse consequences if used.
In a recall notice posted on its website on Thursday, the FDA said that the recall of more than 2.5 million bottles of Lupin’s prednisolone eye drops was because of the “presence of foreign substance.”
The affected bottles come in 5 mL, 10 mL and 15 mL quantities, and were produced by the India-based Lupin, which specializes in manufacturing generic pharmaceutical medications.
The FDA also cautions against simply pausing the use of these medications, suggesting that people who need to use them contact their eye doctor or pharmacist in order to properly react for their own conditions.
